Previous Close | $92.78 |
Intrinsic Value | $3.88 |
Upside potential | -96% |
Data is not available at this time.
Colgate-Palmolive Company operates as a global leader in the consumer goods sector, specializing in oral care, personal care, home care, and pet nutrition. The company generates revenue primarily through the sale of branded products such as Colgate toothpaste, Palmolive dish soap, and Hill’s pet food, distributed across retail and e-commerce channels. Its diversified portfolio and strong brand equity position it competitively in both developed and emerging markets. Colgate-Palmolive leverages extensive R&D capabilities and a robust supply chain to maintain innovation leadership, particularly in oral hygiene, where it holds a dominant market share. The company’s strategic focus on premiumization and sustainability aligns with evolving consumer preferences, reinforcing its resilience against private-label competition. With a presence in over 200 countries, Colgate-Palmolive benefits from geographic diversification, though it faces pricing pressures in inflationary environments. Its market position is further strengthened by long-standing retailer relationships and targeted marketing investments.
Colgate-Palmolive reported FY 2024 revenue of $20.1 billion, with net income of $2.89 billion, reflecting a net margin of approximately 14.4%. Diluted EPS stood at $3.51, supported by disciplined cost management and pricing actions. Operating cash flow of $4.11 billion underscores efficient working capital management, while capital expenditures of $561 million indicate moderate reinvestment needs relative to cash generation.
The company demonstrates consistent earnings power, with operating cash flow covering capital expenditures by a wide margin. Its ability to generate $4.11 billion in operating cash flow against $561 million in capex highlights strong capital efficiency. This allows for sustained dividends and share repurchases, though debt levels warrant monitoring given $8.51 billion in total debt.
Colgate-Palmolive maintains a solid balance sheet with $1.1 billion in cash and equivalents, though its $8.51 billion total debt suggests a leveraged position. The company’s investment-grade credit rating and stable cash flows mitigate liquidity risks. Shareholders’ equity remains healthy, supporting continued dividend payments and strategic flexibility.
Organic growth has been steady, driven by pricing and innovation in core categories. The company’s dividend policy is robust, with a $2.19 annual dividend per share, reflecting a commitment to returning capital to shareholders. Long-term growth hinges on emerging market expansion and premium product adoption, though volume growth remains challenged in mature markets.
At a diluted EPS of $3.51, Colgate-Palmolive trades at a premium valuation relative to peers, reflecting its defensive qualities and consistent cash flow. Market expectations are anchored to mid-single-digit revenue growth and margin stability, with investor focus on the company’s ability to navigate cost inflation and currency headwinds.
Colgate-Palmolive’s strategic advantages include its global brand recognition, innovation pipeline, and distribution scale. The outlook remains stable, with growth initiatives in oral care and pet nutrition offsetting slower categories. Risks include commodity cost volatility and competitive pressures, but the company’s pricing power and cost controls provide resilience.
10-K filing, company investor relations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |